{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:14:58Z","timestamp":1766135698682,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1124\/mol.105.015461","type":"journal-article","created":{"date-parts":[[2005,8,30]],"date-time":"2005-08-30T00:14:02Z","timestamp":1125360842000},"page":"1645-1655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Evidence for a Secondary State of the Human \u03b23-Adrenoceptor"],"prefix":"10.1016","volume":"68","author":[{"given":"Jillian G.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.105.015461_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1011852500209","article-title":"The \u03b23-adrenergic system and \u03b23-adrenergic agonists","volume":"4","author":"Arch","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1124\/mol.105.015461_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(02)01421-8","article-title":"\u03b23-adrenoceptor agonists: potential, pitfalls and progress","volume":"440","author":"Arch","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.105.015461_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.bjp.0705991","article-title":"Do low-affinity states of beta-adrenoceptors have roles in physiology and medicine?","volume":"143","author":"Arch","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.015461_bib4","first-page":"48","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.015461_bib5","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1073\/pnas.1936664100","article-title":"\u03b2-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors","volume":"100","author":"Azzi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.015461_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/jpet.104.082875","article-title":"Sites of action of \u03b2-ligands at the human \u03b21-adrenoceptor","volume":"313","author":"Baker","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.105.015461_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","article-title":"The selectivity of \u03b2-adrenoceptor antagonists at the \u03b21, \u03b22 and \u03b23 adrenoceptors","volume":"144","author":"Baker","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.015461_bib8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1124\/mol.63.6.1312","article-title":"Agonist actions of \u201c\u03b2-blockers\u201d provide evidence for two agonist activation sites or conformations of the human \u03b21-adrenoceptor","volume":"63","author":"Baker","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.015461_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/mol.64.6.1357","article-title":"Agonist and inverse agonist actions of \u201c\u03b2-blockers\u201d at the human \u03b22-adrenoceptor provide evidence for agonist-directed signalling","volume":"64","author":"Baker","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.015461_bib10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/mol.64.3.679","article-title":"Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses","volume":"64","author":"Baker","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.015461_bib11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1124\/mol.65.4.986","article-title":"Temporal characteristics of CRE-mediated gene transcription: requirement for sustained cAMP production","volume":"65","author":"Baker","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.015461_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/236385a0","article-title":"Definition and antagonism of histamine H2 -receptors","volume":"236","author":"Black","year":"1972","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.105.015461_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0026-895X(25)13306-3","article-title":"Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor","volume":"44","author":"Blin","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.015461_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/374272a0","article-title":"Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the \u03b22-adrenoceptor","volume":"374","author":"Bond","year":"1995","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.105.015461_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1476-5381.1992.tb14302.x","article-title":"The effect of pertussis toxin on beta-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure","volume":"106","author":"Brown","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.015461_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0898-6568(94)90093-0","article-title":"Differential interaction of beta 1- and beta 3-adrenergic receptors with Gi in rat adipocytes","volume":"6","author":"Chaudhry","year":"1994","journal-title":"Cell Signal"},{"key":"10.1124\/mol.105.015461_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0026-895X(25)10022-9","article-title":"Inverse agonist activity of \u03b2-adrenergic antagonists","volume":"45","author":"Chidiac","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.015461_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/36362","article-title":"Switching of the coupling of the \u03b22-adrenocergic receptor to different G proteins by protein kinase A","volume":"390","author":"Daaka","year":"1997","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.105.015461_bib19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0006-2952(88)90146-3","article-title":"Influence of rolipram on the cyclic-3\u2032,5\u2032-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex","volume":"37","author":"Donaldson","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.105.015461_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0165-6147(00)01562-5","article-title":"Beta3-adrenoceptors in the cardiovascular system","volume":"21","author":"Gauthier","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.105.015461_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI118823","article-title":"Functional beta3-adrenoceptor in the human heart","volume":"98","author":"Gauthier","year":"1996","journal-title":"J Clin Investig"},{"key":"10.1124\/mol.105.015461_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0026-895X(24)12022-6","article-title":"Stimulation of the extracellular signal-regulated kinase 1\/2 pathway by human \u03b2-3 adrenergic receptor: new pharmacological profile and mechanism of activation","volume":"55","author":"Gerhardt","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.015461_bib23","first-page":"E199","article-title":"The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor","volume":"280","author":"Granneman","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.105.015461_bib24","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.bjp.0705191","article-title":"Cardiac-specific overexpression of human beta2 adrenoceptors in mice exposes coupling to both Gs and Gi proteins","volume":"138","author":"Hasseldine","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.015461_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","article-title":"Comparative pharmacology of human \u03b2-adrenergic receptor subtypes\u2014 characterization of stably transfected receptor in CHO cells","volume":"369","author":"Hoffmann","year":"2004","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/mol.105.015461_bib26","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.bjp.0704654","article-title":"Mouse beta 3a- and beta 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways","volume":"135","author":"Hutchinson","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.015461_bib27","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.104.076901","article-title":"Evidence for pleiotropic signaling at the mouse \u03b23-adrenoceptor revealed by SR59230A [3-(2-ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]","volume":"312","author":"Hutchinson","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.105.015461_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0026-895X(25)09939-0","article-title":"Amplification of cyclic AMP generation reveals agonistic effects of certain \u03b2-adrenergic antagonists","volume":"37","author":"Jasper","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.015461_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00210-004-0884-y","article-title":"Binding of (-)-[3H]-CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers","volume":"369","author":"Joseph","year":"2004","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/mol.105.015461_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-2952(95)00137-O","article-title":"On the importance of the antagonist assumption to how receptors express themselves","volume":"50","author":"Kenakin","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.105.015461_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0022-3565(24)39154-2","article-title":"Aryloxypropanolamine and catecholamine ligand interactions with the \u03b21-adrenergic receptor: evidence for interaction with distinct conformations of \u03b21-adrenergic receptors","volume":"294","author":"Konkar","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.105.015461_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bjp.0704450","article-title":"Comparison of the affinity of \u03b2-blockers for the two states of the \u03b21-adrenoceptor in ferret ventricular myocardium","volume":"135","author":"Lowe","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.015461_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurements with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.015461_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0705420","article-title":"The \u201cstate\u201d of beta-adrenoceptors","volume":"140","author":"Molenaar","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.015461_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1527-3466.2002.tb00079.x","article-title":"Potential use of beta3-adrenoceptor antagonists in heart failure therapy","volume":"20","author":"Moniotte","year":"2002","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1124\/mol.105.015461_bib36","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/01.CIR.103.12.1649","article-title":"Upregulation of beta3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium","volume":"103","author":"Moniotte","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/mol.105.015461_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10799899609039938","article-title":"Anomalous behaviour of CGP 12177A on beta 1-adrenergic receptors","volume":"16","author":"Pak","year":"1996","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1124\/mol.105.015461_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.pharmtox.37.1.421","article-title":"Structure and function of the \u03b23-adrenergic receptor","volume":"37","author":"Strosberg","year":"1997","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24065623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24065623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.105.015461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:00:39Z","timestamp":1740042039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24065623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0026895X24065623"],"URL":"https:\/\/doi.org\/10.1124\/mol.105.015461","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for a Secondary State of the Human \u03b23-Adrenoceptor","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.105.015461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}